# Halobetasol Propionate

NDC: 70752-119
Generic name: Halobetasol Propionate
Labeler / Manufacturer: QUAGEN PHARMACEUTICALS LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: OINTMENT
Routes: TOPICAL
Marketing started: 20201006

FDA application: ANDA213560

## Active ingredients

- HALOBETASOL PROPIONATE: .5 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70752-119"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70752-119
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd4ebec1-e5ba-46cc-9627-4645a7b3bf19